Substance Abuse — Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care
Citation(s)
Anglin MD, Hser YI, Booth MW Sex differences in addict careers. 4. Treatment. Am J Drug Alcohol Abuse. 1987;13(3):253-80. doi: 10.3109/00952998709001513.
Bobo JK, Davis CM Recovering staff and smoking in chemical dependency programs in rural Nebraska. J Subst Abuse Treat. 1993 Mar-Apr;10(2):221-7. doi: 10.1016/0740-5472(93)90047-6.
Bobo JK, Lando HA, Walker RD, McIlvain HE Predictors of tobacco quit attempts among recovering alcoholics. J Subst Abuse. 1996;8(4):431-43. doi: 10.1016/s0899-3289(96)90004-8.
Bodenheimer T, Wagner EH, Grumbach K Improving primary care for patients with chronic illness. JAMA. 2002 Oct 9;288(14):1775-9. doi: 10.1001/jama.288.14.1775.
Bodenheimer T, Wagner EH, Grumbach K Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002 Oct 16;288(15):1909-14. doi: 10.1001/jama.288.15.1909.
Booth BM, Blow FC, Cook CA, Bunn JY, Fortney JC Relationship between inpatient alcoholism treatment and longitudinal changes in health care utilization. J Stud Alcohol. 1997 Nov;58(6):625-37. doi: 10.15288/jsa.1997.58.625.
Booth BM, McLaughlin YS Barriers to and need for alcohol services for women in rural populations. Alcohol Clin Exp Res. 2000 Aug;24(8):1267-75.
Booth BM, Yates WR, Petty F, Brown K Patient factors predicting early alcohol-related readmissions for alcoholics: role of alcoholism severity and psychiatric co-morbidity. J Stud Alcohol. 1991 Jan;52(1):37-43. doi: 10.15288/jsa.1991.52.37.
Brennan PL, Kagay CR, Geppert JJ, Moos RH Elderly Medicare inpatients with substance use disorders: characteristics and predictors of hospital readmissions over a four-year interval. J Stud Alcohol. 2000 Nov;61(6):891-5. doi: 10.15288/jsa.2000.61.891.
Chou SP, Grant BF, Dawson DA Medical consequences of alcohol consumption--United States, 1992. Alcohol Clin Exp Res. 1996 Nov;20(8):1423-9. doi: 10.1111/j.1530-0277.1996.tb01144.x.
Clayton RR Multiple drug use. Epidemiology, correlates, and consequences. Recent Dev Alcohol. 1986;4:7-38.
Compton WM, Thomas YF, Stinson FS, Grant BF Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007 May;64(5):566-76. doi: 10.1001/archpsyc.64.5.566.
Dawson DA, Grant BF Gender effects in diagnosing alcohol abuse and dependence. J Clin Psychol. 1993 Mar;49(2):298-307. doi: 10.1002/1097-4679(199303)49:23.0.co;2-z.
Dennis M, Scott CK Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007 Dec;4(1):45-55. doi: 10.1151/ascp074145.
Dennis ML, Scott CK, Funk R, Foss MA The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28 Suppl 1:S51-62. doi: 10.1016/j.jsat.2004.10.013.
Fleming MF, Graham AW Screening and brief interventions for alcohol use disorders in managed care settings. Recent Dev Alcohol. 2001;15:393-416. doi: 10.1007/978-0-306-47193-3_22.
Friedmann PD, Hendrickson JC, Gerstein DR, Zhang Z, Stein MD Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care? Med Care. 2006 Jan;44(1):8-15. doi: 10.1097/01.mlr.0000188913.50489.77.
Friedmann PD, Jiang L, Richter KP Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat. 2008 Mar;34(2):165-72. doi: 10.1016/j.jsat.2007.02.006. Epub 2007 May 23.
Friedmann PD, Saitz R, Samet JH Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA. 1998 Apr 15;279(15):1227-31. doi: 10.1001/jama.279.15.1227.
Friedmann PD, Zhang Z, Hendrickson J, Stein MD, Gerstein DR Effect of primary medical care on addiction and medical severity in substance abuse treatment programs. J Gen Intern Med. 2003 Jan;18(1):1-8. doi: 10.1046/j.1525-1497.2003.10601.x.
Gfroerer J, Penne M, Pemberton M, Folsom R Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2003 Mar 1;69(2):127-35. doi: 10.1016/s0376-8716(02)00307-1.
Godley MD, Godley SH, Dennis ML, Funk R, Passetti LL Preliminary outcomes from the assertive continuing care experiment for adolescents discharged from residential treatment. J Subst Abuse Treat. 2002 Jul;23(1):21-32. doi: 10.1016/s0740-5472(02)00230-1.
Godley MD, Godley SH, Dennis ML, Funk RR, Passetti LL The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction. 2007 Jan;102(1):81-93. doi: 10.1111/j.1360-0443.2006.01648.x.
Godley SH, Godley MD, Wright KL, Funk RR, Petry NM Contingent reinforcement of personal goal activities for adolescents with substance use disorders during post-residential continuing care. Am J Addict. 2008 Jul-Aug;17(4):278-86. doi: 10.1080/10550490802138798.
Gonzales JJ, Insel TR The conundrum of co-occurring mental and substance use disorders: opportunities for research. Biol Psychiatry. 2004 Nov 15;56(10):723-5. doi: 10.1016/j.biopsych.2004.09.007. No abstract available.
Grella CE, Greenwell L Treatment needs and completion of community-based aftercare among substance-abusing women offenders. Womens Health Issues. 2007 Jul-Aug;17(4):244-55. doi: 10.1016/j.whi.2006.11.005. Epub 2007 Jun 4.
Hassan I, McCabe R, Priebe S Professional-patient communication in the treatment of mental illness: a review. Commun Med. 2007;4(2):141-52. doi: 10.1515/CAM.2007.018.
Hibbard JH, Stockard J, Mahoney ER, Tusler M Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004 Aug;39(4 Pt 1):1005-26. doi: 10.1111/j.1475-6773.2004.00269.x.
Holder HD, Blose JO The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. J Stud Alcohol. 1992 Jul;53(4):293-302. doi: 10.15288/jsa.1992.53.293.
Holman H, Lorig K Patients as partners in managing chronic disease. Partnership is a prerequisite for effective and efficient health care. BMJ. 2000 Feb 26;320(7234):526-7. doi: 10.1136/bmj.320.7234.526. No abstract available.
Hser YI, Anglin MD, Booth MW Sex differences in addict careers. 3. Addiction. Am J Drug Alcohol Abuse. 1987;13(3):231-51. doi: 10.3109/00952998709001512.
Hser YI, Anglin MD, McGlothlin W Sex differences in addict careers. 1. Initiation of use. Am J Drug Alcohol Abuse. 1987;13(1-2):33-57. doi: 10.3109/00952998709001499.
Hser YI, McCarthy WJ, Anglin MD Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med. 1994 Jan;23(1):61-9. doi: 10.1006/pmed.1994.1009.
Hubbard RL Treating combined alcohol and drug abuse in community-based programs. Recent Dev Alcohol. 1990;8:273-83.
Hurt RD, Patten CA Treatment of tobacco dependence in alcoholics. Recent Dev Alcohol. 2003;16:335-59. doi: 10.1007/0-306-47939-7_23.
Jerrell JM, Wieduwilt KM, Macey DV Use and costs of public-sector behavioral health services for african-american and white women. Psychiatr Serv. 2002 Feb;53(2):195-200. doi: 10.1176/appi.ps.53.2.195.
Johnson RL, Roter D, Powe NR, Cooper LA Patient race/ethnicity and quality of patient-physician communication during medical visits. Am J Public Health. 2004 Dec;94(12):2084-90. doi: 10.2105/ajph.94.12.2084.
Kalman D Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice. Subst Use Misuse. 1998 Aug;33(10):2021-47. doi: 10.3109/10826089809069815.
Kania J, Kofoed L Drug use by alcoholics in outpatient treatment. Am J Drug Alcohol Abuse. 1984;10(4):529-34. doi: 10.3109/00952998409001490.
Kaplan SH, Gandek B, Greenfield S, Rogers W, Ware JE Patient and visit characteristics related to physicians' participatory decision-making style. Results from the Medical Outcomes Study. Med Care. 1995 Dec;33(12):1176-87. doi: 10.1097/00005650-199512000-00002.
Liberto JG, Oslin DW, Ruskin PE Alcoholism in older persons: a review of the literature. Hosp Community Psychiatry. 1992 Oct;43(10):975-84. doi: 10.1176/ps.43.10.975.
Lorig KR, Holman H Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med. 2003 Aug;26(1):1-7. doi: 10.1207/S15324796ABM2601_01.
Marsh JC, Cao D, D'Aunno T Gender differences in the impact of comprehensive services in substance abuse treatment. J Subst Abuse Treat. 2004 Dec;27(4):289-300. doi: 10.1016/j.jsat.2004.08.004.
McKay JR, Carise D State of the science: Extending the benefits of addiction treatment. J Subst Abuse Treat. 2009 Mar;36(2):172-3. doi: 10.1016/j.jsat.2008.10.007. No abstract available.
McKay JR, Lynch KG, Shepard DS, Pettinati HM The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry. 2005 Feb;62(2):199-207. doi: 10.1001/archpsyc.62.2.199.
McKay JR Continuing care research: what we have learned and where we are going. J Subst Abuse Treat. 2009 Mar;36(2):131-45. doi: 10.1016/j.jsat.2008.10.004.
McKay JR Is there a case for extended interventions for alcohol and drug use disorders? Addiction. 2005 Nov;100(11):1594-610. doi: 10.1111/j.1360-0443.2005.01208.x.
Mendelson DN, Schwartz WB The effects of aging and population growth on health care costs. Health Aff (Millwood). 1993 Spring;12(1):119-25. doi: 10.1377/hlthaff.12.1.119.
Mertens JR, Flisher AJ, Satre DD, Weisner CM The role of medical conditions and primary care services in 5-year substance use outcomes among chemical dependency treatment patients. Drug Alcohol Depend. 2008 Nov 1;98(1-2):45-53. doi: 10.1016/j.drugalcdep.2008.04.007. Epub 2008 Jun 20.
Mertens JR, Lu YW, Parthasarathy S, Moore C, Weisner CM Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO: comparison with matched controls. Arch Intern Med. 2003 Nov 10;163(20):2511-7. doi: 10.1001/archinte.163.20.2511.
Mertens JR, Weisner CM Predictors of substance abuse treatment retention among women and men in an HMO. Alcohol Clin Exp Res. 2000 Oct;24(10):1525-33.
Montoya ID Infectious diseases and anemia in a sample of out-of-treatment drug users. Am J Manag Care. 1998 Sep;4(9):1257-64.
Moos RH, Brennan PL, Mertens JR Diagnostic subgroups and predictors of one-year re-admission among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1994 Mar;55(2):173-83. doi: 10.15288/jsa.1994.55.173.
Moos RH, Mertens JR, Brennan PL Patterns of diagnosis and treatment among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1993 Jul;54(4):479-87. doi: 10.15288/jsa.1993.54.479.
Moos RH, Mertens JR, Brennan PL Rates and predictors of four-year readmission among late-middle-aged and older substance abuse patients. J Stud Alcohol. 1994 Sep;55(5):561-70. doi: 10.15288/jsa.1994.55.561.
Myers MG, MacPherson L Smoking cessation efforts among substance abusing adolescents. Drug Alcohol Depend. 2004 Feb 7;73(2):209-13. doi: 10.1016/j.drugalcdep.2003.09.008.
Nease RF Jr, Brooks WB Patient desire for information and decision making in health care decisions: the Autonomy Preference Index and the Health Opinion Survey. J Gen Intern Med. 1995 Nov;10(11):593-600. doi: 10.1007/BF02602742.
Ornstein P, Cherepon JA Demographic variables as predictors of alcoholism treatment outcome. J Stud Alcohol. 1985 Sep;46(5):425-32. doi: 10.15288/jsa.1985.46.425.
Oslin DW, Pettinati H, Volpicelli JR Alcoholism treatment adherence: older age predicts better adherence and drinking outcomes. Am J Geriatr Psychiatry. 2002 Nov-Dec;10(6):740-7.
Oslin DW Alcohol use in late life: disability and comorbidity. J Geriatr Psychiatry Neurol. 2000 Fall;13(3):134-40. doi: 10.1177/089198870001300307.
Parthasarathy S, Weisner CM Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample. Drug Alcohol Depend. 2005 Nov 1;80(2):231-40. doi: 10.1016/j.drugalcdep.2005.04.004.
Phibbs CS, Swindle RW, Recine B Does case mix matter for substance abuse treatment? A comparison of observed and case mix-adjusted readmission rates for inpatient substance abuse treatment in the Department of Veterans Affairs. Health Serv Res. 1997 Feb;31(6):755-71.
Redelmeier DA, Tan SH, Booth GL The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998 May 21;338(21):1516-20. doi: 10.1056/NEJM199805213382106.
Rice C, Longabaugh R, Beattie M, Noel N Age group differences in response to treatment for problematic alcohol use. Addiction. 1993 Oct;88(10):1369-75. doi: 10.1111/j.1360-0443.1993.tb02023.x.
Ritsher JB, McKellar JD, Finney JW, Otilingam PG, Moos RH Psychiatric comorbidity, continuing care and mutual help as predictors of five-year remission from substance use disorders. J Stud Alcohol. 2002 Nov;63(6):709-15. doi: 10.15288/jsa.2002.63.709.
Roman PM Biological features of women's alcohol use: a review. Public Health Rep. 1988 Nov-Dec;103(6):628-37.
Saitz R, Horton NJ, Larson MJ, Winter M, Samet JH Primary medical care and reductions in addiction severity: a prospective cohort study. Addiction. 2005 Jan;100(1):70-8. doi: 10.1111/j.1360-0443.2005.00916.x.
Saitz R, Larson MJ, Horton NJ, Winter M, Samet JH Linkage with primary medical care in a prospective cohort of adults with addictions in inpatient detoxification: room for improvement. Health Serv Res. 2004 Jun;39(3):587-606. doi: 10.1111/j.1475-6773.2004.00246.x.
Samet JH, Friedmann P, Saitz R Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives. Arch Intern Med. 2001 Jan 8;161(1):85-91. doi: 10.1001/archinte.161.1.85.
Samet JH, Larson MJ, Horton NJ, Doyle K, Winter M, Saitz R Linking alcohol- and drug-dependent adults to primary medical care: a randomized controlled trial of a multi-disciplinary health intervention in a detoxification unit. Addiction. 2003 Apr;98(4):509-16. doi: 10.1046/j.1360-0443.2003.00328.x.
Satre DD, Gordon NP, Weisner C Alcohol consumption, medical conditions, and health behavior in older adults. Am J Health Behav. 2007 May-Jun;31(3):238-48. doi: 10.5555/ajhb.2007.31.3.238.
Satre DD, Mertens J, Arean PA, Weisner C Contrasting outcomes of older versus middle-aged and younger adult chemical dependency patients in a managed care program. J Stud Alcohol. 2003 Jul;64(4):520-30. doi: 10.15288/jsa.2003.64.520.
Satre DD, Mertens JR, Arean PA, Weisner C Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program. Addiction. 2004 Oct;99(10):1286-97. doi: 10.1111/j.1360-0443.2004.00831.x.
Schmittdiel J, Mosen DM, Glasgow RE, Hibbard J, Remmers C, Bellows J Patient Assessment of Chronic Illness Care (PACIC) and improved patient-centered outcomes for chronic conditions. J Gen Intern Med. 2008 Jan;23(1):77-80. doi: 10.1007/s11606-007-0452-5. Epub 2007 Nov 21.
Schuckit MA, Smith TL An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry. 1996 Mar;53(3):202-10. doi: 10.1001/archpsyc.1996.01830030020005.
Seshamani M, Gray A Health care expenditures and ageing: an international comparison. Appl Health Econ Health Policy. 2003;2(1):9-16.
Skog OJ, Duckert F The development of alcoholics' and heavy drinkers' consumption: a longitudinal study. J Stud Alcohol. 1993 Mar;54(2):178-88. doi: 10.15288/jsa.1993.54.178.
Stein MD Medical consequences of substance abuse. Psychiatr Clin North Am. 1999 Jun;22(2):351-70. doi: 10.1016/s0193-953x(05)70081-2.
Sterling S, Chi F, Campbell C, Weisner C Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug;33(8):1417-29. doi: 10.1111/j.1530-0277.2009.00972.x. Epub 2009 Apr 30.
Street RL Jr, Gordon HS, Ward MM, Krupat E, Kravitz RL Patient participation in medical consultations: why some patients are more involved than others. Med Care. 2005 Oct;43(10):960-9. doi: 10.1097/01.mlr.0000178172.40344.70.
Street RL Jr Gender differences in health care provider-patient communication: are they due to style, stereotypes, or accommodation? Patient Educ Couns. 2002 Dec;48(3):201-6. doi: 10.1016/s0738-3991(02)00171-4.
Tam TW, Weisner C, Mertens J Demographic characteristics, life context, and patterns of substance use among alcohol-dependent treatment clients in a health maintenance organization. Alcohol Clin Exp Res. 2000 Dec;24(12):1803-10.
Volkow ND The reality of comorbidity: depression and drug abuse. Biol Psychiatry. 2004 Nov 15;56(10):714-7. doi: 10.1016/j.biopsych.2004.07.007. No abstract available.
Weisner C, Matzger H, Tam T, Schmidt L Who goes to alcohol and drug treatment? Understanding utilization within the context of insurance. J Stud Alcohol. 2002 Nov;63(6):673-82. doi: 10.15288/jsa.2002.63.673.
Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001 Oct 10;286(14):1715-23. doi: 10.1001/jama.286.14.1715.
Weisner C, Ray GT, Mertens JR, Satre DD, Moore C Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug Alcohol Depend. 2003 Sep 10;71(3):281-94. doi: 10.1016/s0376-8716(03)00167-4.
Weisner C The merging of alcohol and drug treatment: a policy review. J Public Health Policy. 1992 Spring;13(1):66-80.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
